These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16315923)

  • 1. [Gemcitabine concurrent with radiation for locally advanced pancreatic cancer].
    Baba H; Suzuki Y; Ema T; Kawakami M; Nakanishi C; Hashimoto T; Arai T; Matsumoto G; Tsuruta K; Okamoto A; Karasawa K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1730-2. PubMed ID: 16315923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-dose gemcitabine concurrent with radiation therapy for locally advanced pancreatic carcinoma].
    Baba H; Kurata M; Tsuruta K; Okamoto A; Karasawa K
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1863-5. PubMed ID: 17212129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concurrent chemoradiotherapy using full-dose gemcitabine for patients with unresectable pancreatic cancer].
    Yamazaki H; Nishiyama K; Koizumi M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2004 May; 64(4):216-9. PubMed ID: 15211883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival.
    Ogawa K; Ito Y; Hirokawa N; Shibuya K; Kokubo M; Ogo E; Shibuya H; Saito T; Onishi H; Karasawa K; Nemoto K; Nishimura Y;
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):559-65. PubMed ID: 22019243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and factors affecting outcome of gemcitabine concurrent chemoradiotherapy in patients with locally advanced pancreatic cancer.
    Huang PI; Chao Y; Li CP; Lee RC; Chi KH; Shiau CY; Wang LW; Yen SH
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):159-65. PubMed ID: 18508203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of locally advanced pancreatic cancer with superior membrane artery invasion successfully resected after gemcitabine-based chemoradiotherapy].
    Ohmura Y; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Kitagawa T; Monden M; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2428-9. PubMed ID: 20037445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.
    Mohiuddin M; Kudrimoti M; Regine WF; McGrath PC; Hanna N; John W
    Cancer J; 2002; 8(3):255-62. PubMed ID: 12074325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after chemoradiation in resected pancreatic cancer: the impact of adjuvant gemcitabine.
    Baschnagel A; Shah C; Margolis J; Nadeau L; Stein J; Jury R; Robertson JM
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e331-5. PubMed ID: 22420967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study.
    Demols A; Peeters M; Polus M; Honoré P; Boterberg T; Gay F; Closon MT; Van Houtte P; Closset J; Van Laethem JL
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1351-6. PubMed ID: 16029792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.
    Ohigashi H; Ishikawa O; Eguchi H; Takahashi H; Gotoh K; Yamada T; Yano M; Nakaizumi A; Uehara H; Tomita Y; Nishiyama K
    Ann Surg; 2009 Jul; 250(1):88-95. PubMed ID: 19561477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer.
    Joensuu TK; Kiviluoto T; Kärkkäinen P; Vento P; Kivisaari L; Tenhunen M; Westberg R; Elomaa I
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):444-52. PubMed ID: 15380578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy for advanced pancreatic cancer: 1,000 mg/m2 gemcitabine can be administered using limited-field radiotherapy.
    Yamazaki H; Nishiyama K; Koizumi M; Tanaka E; Ioka T; Uehara H; Iishi H; Nakaizumi A; Ohigashi H; Ishikawa O
    Strahlenther Onkol; 2007 Jun; 183(6):301-6. PubMed ID: 17520183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma.
    Huang J; Robertson JM; Ye H; Margolis J; Nadeau L; Yan D
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1120-5. PubMed ID: 22099048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction gemcitabine plus concurrent gemcitabine and radiotherapy for locally advanced unresectable or resected pancreatic cancer.
    Youl M; Hashem S; Brade A; Cummings B; Dawson LA; Gallinger S; Hedley D; Jiang H; Kim J; Krzyzanowska MK; Ringash J; Wong R; Brierley J
    Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):203-9. PubMed ID: 24462333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon Ion Radiation Therapy With Concurrent Gemcitabine for Patients With Locally Advanced Pancreatic Cancer.
    Shinoto M; Yamada S; Terashima K; Yasuda S; Shioyama Y; Honda H; Kamada T; Tsujii H; Saisho H;
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):498-504. PubMed ID: 26883565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer.
    Murphy JD; Adusumilli S; Griffith KA; Ray ME; Zalupski MM; Lawrence TS; Ben-Josef E
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):801-8. PubMed ID: 17379445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
    Allen AM; Zalupski MM; Robertson JM; Eckhauser FE; Simone D; Brown D; Hejna G; Normolle D; Lawrence TS; McGinn CJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1461-7. PubMed ID: 15275733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer.
    Yavuz AA; Aydin F; Yavuz MN; Ilis E; Ozdemir F
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):974-81. PubMed ID: 11704320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer.
    Sangar VK; McBain CA; Lyons J; Ramani VA; Logue JP; Wylie JP; Clarke NW; Cowan RA
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):420-5. PubMed ID: 15667962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.